HOME >> MEDICINE >> NEWS
News tips for Wednesday, Nov. 12, 2003

2 p.m. Abstract #3544 Results of hormone replacement study get rapid acceptance. Findings of last year's Women's Health Initiative (WHI) trial that hormone replacement therapy (HRT) with estrogen (E) plus progesterone (P) in post-menopausal women leads to excessive risk of cardiovascular disease is resulting in a "clear global decrease" in the use of HRT, a new study finds. Researchers assessed the impact of the WHI publication among 6,623 women, age 55 and over, taking part in an ongoing international drug trial. They found that 3.4 percent of North American women in that study were on E+P HRT after the WHI report, down from 5.9 percent before the report. Their results indicate a rapid acceptance of the results of the WHI trial both in North America and other countries, the scientists say. And despite a lack of data on effects of HRT with E alone, this therapy also was down in North American women, from 26 percent of post-menopausal women before the WHI report to 17.7 percent after.

2:15 p.m. Abstract #3099 Excess daytime sleepiness affects angina patients' quality of life. Sleep disturbances are a common problem among patients with coronary artery disease (CAD). New research finds that excessive daytime sleepiness predicts a poorer quality of life of CAD patients with chronic stable angina (chest pain). The Emory University study of 57 angina patients assessed quality of life (QOL) aspects via standard questionnaires, at baseline and follow-ups of one, three and four months. Extent of daytime sleepiness also was evaluated along with numerous other factors including years with CAD, body mass index and extent of other health problems. After controlling for clinical and demographic variables, researchers found daytime sleepiness to be "a significant negative predictor of QOL" in four statistical models studied. "Daytime sleepiness had pervasive and detrimental effects on chronic angina patients' QOL including generic and disease-s
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
12-Nov-2003


Page: 1 2 3 4

Related medicine news :

1. News tips for Wednesday, November 10, 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO ... new 2.0 version at the International Roofing Expo in Orlando, Florida on February ... world's most advanced weather technology in the hands of consumers, roofing contractors, manufacturers ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... American Academy of Emergency Medicine , an emergency medicine professional association, ... practice management services . , The American Academy of Emergency Medicine, or AAEM, ...
(Date:2/10/2016)... ... 10, 2016 , ... Emergency rooms provide emergency care to stabilize critical health ... patients with dental emergencies at risk of losing a tooth or their smiles. Dr. ... , Common dental emergencies include:, , Avulsed or knocked-out teeth ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. Jessica Barron, of Barron ... accepting new dental patients and families in the North Metro Denver area. The new ... cleanings to cosmetic dentistry, and all in the most relaxing environment. , While some ...
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit Advisors (UBA), ... latest addition to its growing list of Partner Firms. S.S. Nesbitt is ... Orlando to Huntsville and in between. , Harnessing the experience and insights of ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... viral gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical ... and other chronic diseases, have entered into a Manufacturing ... produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in ... --> This relationship will leverage Lonza,s ...
(Date:2/10/2016)... Calif. , Feb. 10, 2016  Rich Pharmaceuticals, ... today announced a 1-for-100 reverse split of its issued ... opening of trading on Thursday, February 11, 2016. The ... under new CUSIP number 76303T308 and temporary ticker symbol ... commence trading under the ticker symbol (RCHA).  ...
(Date:2/10/2016)... , Feb. 10, 2016  The ALS Association, in partnership ... Grand Challenge to generate a biomarker to track TDP43 aggregation. ... up to a $1 million investment. ... disease that affects nerve cells in the brain and the ... initiate and control muscle movement, which often leads to total ...
Breaking Medicine Technology:
Cached News: